We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 164 results
  1. Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations

    Background:

    Male breast cancer (MBC) is still poorly understood with a large proportion arising in families with a history of breast cancer. Genomic...

    S Deb, S Q Wong, ... S B Fox in British Journal of Cancer
    Article Open access 09 December 2014
  2. Germline TP53 mutational spectrum in French Canadians with breast cancer

    Background

    Specific germline mutations in the hereditary breast-ovarian cancer susceptibility (HBC/HBOC) genes, BRCA1, BRCA2 and PALB2, have been...

    Suzanna L Arcand, Mohammed R Akbari, ... Patricia N Tonin in BMC Medical Genetics
    Article Open access 12 April 2015
  3. TP53 Arg 72Pro and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: A West Algerian Population Study

    The tumor suppressor gene TP53 and its regulator MDM2 are both key players involved in multiple pathways including apoptosis, cellular...

    Rym Abderrahmane, Lotfi Louhibi, ... Nadhira Saidi-Mehtar in Pathology & Oncology Research
    Article 24 December 2014
  4. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer

    Identification of biomarkers used for the prognostic evaluation of non-small cell lung cancer (NSCLC) patients is important. The aim of this study...

    Caglayan Geredeli, Mehmet Artac, ... Ahmet Demirkazik in Tumor Biology
    Article 18 January 2015
  5. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases

    Emerging evidence has shown that p53 gene participates in human carcinogenesis as tumor suppressors. Polymorphism of p53 gene codon72 arginine...

    Surong Hu, Lianying Zhao, ... Miao Hu in Tumor Biology
    Article 11 December 2013
  6. Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling

    Background

    Monolayer cultures of immortalised cell lines are a popular screening tool for novel anti-cancer therapeutics, but these methods can be a...

    Alan M. Sandercock, Steven Rust, ... Ralph Minter in Molecular Cancer
    Article Open access 31 July 2015
  7. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis

    Background

    Several epidemiological studies have previously investigated the association between the TP53 codon 72 polymorphism and oral squamous cell...

    **an-Tao Zeng, Wei Luo, ... Wei-Dong Leng in BMC Cancer
    Article Open access 26 June 2014
  8. Association of P53 (−16ins-Pro) Haplotype with the Decreased Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients

    Association of P53 polymorphisms with the increased risk of various cancers has been investigated in numerous studies. However, the results were...

    Roghayeh Dehghan, Mohammad Ali Hosseinpour Feizi, ... Masoumeh Nemati in Pathology & Oncology Research
    Article 20 November 2014
  9. In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients

    Background

    In osteosarcoma (OS) and most Ewing sarcoma (EWS) patients, the primary tumor originates in the bone. Although tumor resection surgery is...

    Enrico Lucarelli, Chiara Bellotti, ... Serena Duchi in Journal of Translational Medicine
    Article Open access 09 April 2014
  10. Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy

    Background

    Ovarian malignancies are often diagnosed in advanced stage and at the same time resistance to treatment, both intrinsic and developed...

    Karolina Tecza, Jolanta Pamula-Pilat, ... Ewa Grzybowska in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 January 2015
  11. Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer

    Background

    This study aimed to determine whether single nucleotide polymorphisms (SNPs) in genes involved in DNA repair or metabolism of taxanes or...

    Sandrina Lambrechts, Diether Lambrechts, ... Ignace Vergote in BMC Pharmacology and Toxicology
    Article Open access 27 February 2015
  12. Lung cancer risk and genetic variants in East Asians: a meta-analysis

    Inconsistent results are often found regarding the risk of genetic variants in lung cancer association studies. To alleviate these conflicts, we...

    Qu Zhang, Hong **, ... Sitong Sheng in Tumor Biology
    Article 11 February 2014
  13. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism

    We tested apoptosis levels in in vitro irradiated T-lymphocytes from breast cancer (BC) patients with radiotherapy-induced late effects. Previous...

    María J. Fuentes-Raspall, Isabel Caragol, ... Sara Gutiérrez-Enríquez in Apoptosis
    Article 15 November 2014
  14. A pilot study evaluating genetic alterations that drive tobacco- and betel quid-associated oral cancer in Northeast India

    The susceptibility of an individual to oral cancer is mediated by genetic factors and carcinogen-exposure behaviors such as betel quid chewing,...

    Dhirendra Singh Yadav, Indranil Chattopadhyay, ... Sujala Kapur in Tumor Biology
    Article 19 June 2014
  15. Lung Cancer: Diagnosis and Treatment Approach

    Lung cancer is one of the most common causes of cancer death in the world. There are many risk factors for lung cancer including tobacco smoking,...
    Apichat Tantraworasin, Thatthan Suksomboonchroen, ... Busayamas Chewaskulyong in International Manual of Oncology Practice
    Chapter 2015
  16. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk

    TP53 Arg72Pro polymorphism has been proposed to have some effects on host’s susceptibility to cancer. Several studies were published to assess the...

    Fang Wang, Peng Wang, ... Yan-Gang Wang in Tumor Biology
    Article 28 December 2013
  17. Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk

    Cervical cancer incidence has grown worldwide, with it being a more significant problem in develo** countries. Invasive squamous cell cervical...

    Tatiana Dantas Rodrigues Laprano, Érika Hardy Lemos, ... Silvia Helena Barem Rabenhorst in Tumor Biology
    Article 30 April 2014
Did you find what you were looking for? Share feedback.